Pure Extracts Technologies Corp. (PRXTF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Pure Extracts Technologies Corp. (PRXTF) trades at $0.0054. Pure Extracts Technologies Corp. focuses on cannabis, hemp, and functional mushroom extraction and processing in Canada. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for PRXTF: PRXTF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates PRXTF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
PRXTF: 3/3 scored disciplines lean bearish. Dominant signal: Jim Simons bearish.
How is this calculated? →Pure Extracts Technologies Corp. (PRXTF) Healthcare & Pipeline Overview
Pure Extracts Technologies Corp. is a Canadian company specializing in the extraction and processing of cannabis, hemp, and functional mushrooms, producing oils and derivative products. The company focuses on developing wellness and medical products, positioning itself in the emerging market for natural health solutions within the Canadian healthcare sector.
What Is the Investment Thesis for PRXTF?
Pure Extracts Technologies Corp. presents a speculative investment opportunity in the emerging cannabis and functional mushroom market. The company's focus on extraction and product development could drive revenue growth as the market matures. However, negative profit and gross margins of -426.5% and -215.7%, respectively, indicate significant financial challenges. The company's high beta of 2.17 suggests high volatility relative to the market. Successful commercialization of its product pipeline and effective cost management are critical for achieving profitability. Investors should carefully consider the risks associated with investing in a small-cap company operating in a rapidly evolving and highly regulated industry.
Based on FMP financials and quantitative analysis
PRXTF Key Highlights
Market Cap of $0.00B indicates a micro-cap company with high growth potential but also significant risk.
- P/E Ratio of -0.19 reflects the company's current lack of profitability.
- Profit Margin of -426.5% suggests substantial operational inefficiencies and high costs.
- Gross Margin of -215.7% indicates that the company's cost of goods sold exceeds its revenue.
- Beta of 2.17 implies the stock is more volatile than the overall market, potentially offering higher returns but also greater risk.
Who Are PRXTF's Competitors?
PRXTF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are PRXTF's Key Strengths?
Expertise in extraction and processing of cannabis, hemp, and functional mushrooms.
- Diversified product portfolio including oils, wellness products, and potential medical applications.
- Early mover advantage in the emerging functional mushroom market.
- Strategic focus on developing innovative therapies.
What Are PRXTF's Weaknesses?
Negative profit and gross margins indicate financial instability.
- Limited geographic presence primarily in Canada.
- Dependence on regulatory approvals for psychedelic medical products.
- Small market capitalization increases volatility and risk.
What Could Drive PRXTF Stock Higher?
Potential regulatory approvals for psychedelic medical products.
- Expansion of product offerings in the cannabis and functional mushroom markets.
- Strategic partnerships to expand market reach and access new technologies.
What Are the Key Risks for PRXTF?
Financial-distress signal — its Altman Z-Score of -10.97 sits in the distress zone (elevated bankruptcy risk).
- Intense competition in the cannabis and wellness industries.
- Fluctuations in commodity prices for cannabis and hemp.
- Delays or setbacks in the development of psychedelic medical products.
- Negative profit and gross margins indicate financial instability.
- Changes in regulations and compliance requirements.
What Are the Growth Opportunities for PRXTF?
- Expansion into new product lines: Pure Extracts Technologies Corp. can expand its product offerings to include a wider range of cannabis-infused products, such as edibles, beverages, and topicals. The global cannabis edibles market is projected to reach $XX billion by 202X, presenting a significant growth opportunity. Successful product diversification could increase revenue streams and enhance brand recognition.
- Geographic expansion: Pure Extracts Technologies Corp. can expand its operations into new geographic markets, particularly in regions where cannabis legalization is progressing. The European cannabis market is expected to experience substantial growth in the coming years, offering a promising avenue for expansion. Entering new markets would require navigating regulatory complexities and establishing distribution networks.
- Strategic partnerships: Pure Extracts Technologies Corp. can form strategic partnerships with other companies in the cannabis and wellness industries to expand its reach and access new technologies. Collaborating with established brands or research institutions could accelerate product development and market penetration. Identifying synergistic partners is crucial for maximizing the benefits of such alliances.
- Development of psychedelic medical products: Pure Extracts Technologies Corp. is involved in the development of psychedelic medical products, positioning itself at the forefront of innovative therapies. The market for psychedelic-assisted therapies is expected to grow significantly as research progresses and regulatory approvals are granted. Successful development and commercialization of these products could generate substantial revenue and establish the company as a leader in this emerging field.
- Increased focus on functional mushroom products: Pure Extracts Technologies Corp. can capitalize on the growing demand for functional mushroom wellness products by expanding its product line and marketing efforts. The global functional mushroom market is projected to reach $XX billion by 202X, driven by increasing consumer awareness of the health benefits of these products. Investing in research and development to create innovative mushroom-based products could drive revenue growth.
What Are PRXTF's Competitive Advantages?
- Proprietary extraction and processing techniques.
- Early mover advantage in the functional mushroom market.
- Potential intellectual property related to psychedelic medical products.
- Established presence in the Canadian cannabis market.
What Does PRXTF Do?
Pure Extracts Technologies Corp., formerly known as Big Sky Petroleum Corporation, was rebranded in October 2020 to focus on the extraction and processing of cannabis, hemp, and functional mushrooms. Headquartered in Pemberton, Canada, the company produces THC and CBD-based extracted oils, catering to the growing demand for cannabis-derived products. Pure Extracts is also involved in the development and commercialization of functional mushroom wellness products, tapping into the expanding market for natural health supplements. Furthermore, the company is exploring psychedelic medical products, positioning itself at the forefront of innovative therapies. The company's operations are currently based in Canada, with potential for future expansion into other regulated markets. Pure Extracts aims to leverage its extraction expertise and product development capabilities to establish a strong presence in the evolving cannabis and wellness industries.
What Products and Services Does PRXTF Offer?
- Extracts and processes cannabis to produce oils.
- Extracts and processes hemp to produce oils.
- Extracts and processes functional mushrooms to produce various derivative products.
- Offers THC and CBD based extracted oils.
- Develops and commercializes functional mushroom wellness products.
- Engages in the development of psychedelic medical products.
How Does PRXTF Make Money?
- Extraction and processing of cannabis, hemp, and functional mushrooms.
- Sale of THC and CBD-based extracted oils.
- Commercialization of functional mushroom wellness products.
- Development of psychedelic medical products for potential future revenue.
What Industry Does PRXTF Operate In?
Pure Extracts Technologies Corp. operates in the rapidly growing cannabis and functional mushroom industries. The functional mushroom market is also experiencing significant growth, fueled by rising consumer interest in natural health and wellness products. Competition in these industries is intense, with numerous companies vying for market share. Pure Extracts aims to differentiate itself through its extraction expertise, product innovation, and focus on high-quality ingredients.
Who Are PRXTF's Key Customers?
- Consumers seeking THC and CBD-based products.
- Individuals interested in functional mushroom wellness products.
- Potential patients seeking psychedelic medical treatments (future).
Company Profile
Pure Extracts Technologies Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Pemberton, CA. The company is led by CEO Ben Nikolaevsky. PRXTF has traded publicly since 2021.
Key Financial Metrics
Return on assets is -82.9%, showing how much profit it generates from its asset base. A current ratio of 0.69 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Pure Extracts Technologies Corp.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -10.97 places it in the distress zone, a signal of elevated financial risk.
PRXTF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, indicating that management believes in its growth potential.
- Community sentiment has turned positive with discussions around new product launches and expansion into emerging markets gaining traction.
- The increasing interest in plant-based products aligns with market trends, positioning Pure Extracts favorably for future demand.
- Recent partnerships with established brands hint at potential revenue growth and enhanced market presence, boosting investor optimism.
Bear Case
- Concerns over regulatory challenges in the cannabis industry may weigh on investor sentiment, creating uncertainty around future operations.
- Market perception remains cautious due to the volatility in the sector, with some community members expressing skepticism about long-term viability.
- Limited financial disclosures in recent weeks have led to questions about transparency and overall business health, causing hesitation among investors.
- Increased competition from larger players in the cannabis space could impact market share and profitability, leading to bearish outlooks among some analysts.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
PRXTF Latest News
No recent news available for PRXTF.
PRXTF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PRXTF.
Price Targets
Wall Street price target analysis for PRXTF.
PRXTF MoonshotScore
What does this score mean?
The MoonshotScore rates PRXTF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Ben Nikolaevsky
CEO
Ben Nikolaevsky serves as the CEO of Pure Extracts Technologies Corp. His background includes experience in the cannabis and resource sectors. He has been involved in various aspects of business development, including strategic planning, financing, and operations. Nikolaevsky's expertise lies in identifying and capitalizing on emerging market opportunities. He is focused on driving growth and innovation within Pure Extracts Technologies Corp.
Track Record: Under Ben Nikolaevsky's leadership, Pure Extracts Technologies Corp. has transitioned from Big Sky Petroleum Corporation to a company focused on cannabis, hemp, and functional mushroom extraction. He has overseen the development of the company's product portfolio and the expansion of its operations. Nikolaevsky has been instrumental in securing financing and establishing strategic partnerships to support the company's growth initiatives.
PRXTF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Pure Extracts Technologies Corp. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited information available to investors and may be subject to less regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries a higher degree of risk due to the potential for limited liquidity, price volatility, and information asymmetry.
- OTC Tier: OTC Other
- Limited liquidity and price volatility due to low trading volume.
- Lack of regulatory oversight and potential for information asymmetry.
- Higher risk of fraud or manipulation compared to major exchanges.
- Limited access to capital and potential for financial distress.
- Uncertainty regarding the company's long-term viability.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's management team and their track record.
- Evaluate the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a qualified financial advisor.
- Research the company's history and any past legal or regulatory issues.
- The company has a functioning website and contact information.
- The company has a CEO and management team.
- The company is involved in a legitimate industry (cannabis, hemp, functional mushrooms).
- The company has been operating for several years (since 2020).
- The company has a physical headquarters in Pemberton, Canada.
Common Questions About PRXTF (Healthcare)
What does Pure Extracts Technologies Corp. do?
Pure Extracts Technologies Corp. is a Canadian company focused on the extraction and processing of cannabis, hemp, and functional mushrooms. They produce THC and CBD-based extracted oils and are developing functional mushroom wellness products. Additionally, they are exploring psychedelic medical products.
What do analysts say about PRXTF stock?
As of March 18, 2026, there is no readily available analyst coverage specifically for PRXTF stock due to its OTC listing and small market capitalization. Investors should conduct their own independent research and consider the company's financial performance, growth prospects, and risk factors before making any investment decisions.
What are the main risks for PRXTF?
The main risks for Pure Extracts Technologies Corp. include intense competition in the cannabis and wellness industries, fluctuations in commodity prices for cannabis and hemp, and potential delays or setbacks in the development of psychedelic medical products. The company's negative profit and gross margins indicate financial instability, and changes in regulations and compliance requirements could also pose challenges.
What are the key factors to evaluate for PRXTF?
Evaluate PRXTF on fundamentals, analyst consensus, and risk factors. Pure Extracts Technologies Corp. presents a speculative investment opportunity in the emerging cannabis and functional mushroom market. Not financial advice.
How frequently does PRXTF data refresh on this page?
PRXTF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven PRXTF's recent stock price performance?
Pure Extracts Technologies Corp. (PRXTF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Expertise in extraction and processing of cannabis, hemp, and functional mushrooms. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider PRXTF overvalued or undervalued right now?
Pure Extracts Technologies Corp. (PRXTF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research PRXTF before investing?
Before investing in Pure Extracts Technologies Corp. (PRXTF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited and may not be fully up-to-date.
- Analyst coverage is not available for this stock.
- OTC market investments carry significant risk.